person · Reporting owner
Gocal Gregory Francis William
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cibus, Inc.CBUS · Entity 6658 | Chief Scientific Officer & EVP | April 24, 2026 | April 28, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cibus, Inc.
Report date April 24, 2026 · Filed April 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 422,890 |
Reported balance
After 2026-04-24 transaction · row 1
1 source rowRow 1 · 2026-04-24 · Grant · Acquired 57,000 · Balance 422,890 |
| Stock Option (Right-to-Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.50 · Expires 2036-04-24 | Direct | 114,000 |
Reported balance
After 2026-04-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-04-24 · Grant · Acquired 114,000 · Balance 114,000 F1: 1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant. |
Filing footnotes · ownership attribution and instrument terms
F1: 1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2026 Filed Apr 28, 2026 17:57 UTC | Cibus, Inc. CBUS · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 114,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0001615594-26-000026 · primary_doc.xml · derivative · entry 2 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,000 Underlying: Class A Common Stock · 114,000 shares Expires 2036-04-24 F1 · derivative.expiration_date: 1/48th of the total options vest monthly on the 24th of each month until the fourth anniversary of the date of the grant. Read SEC document |
| April 24, 2026 Filed Apr 28, 2026 17:57 UTC | Cibus, Inc. CBUS · Entity 6658 | GrantClass A Common Stock | 57,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-26-000026 · primary_doc.xml · nonDerivative · entry 1 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 422,890 Read SEC document |
| March 30, 2026 Filed Apr 1, 2026 15:52 UTC | Cibus, Inc. CBUS · Entity 6658 | Tax withholdingClass A Common Stock | 8,954 | $1.82 | $16,296.28 |
DisclosureSEC source: 0001615594-26-000015 · primary_doc.xml · nonDerivative · entry 1 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,890 F1 · price: The price provided is a weighted average. The shares were sold in multiple transactions at prices ranging from $1.795 to $1.86, inclusive. Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 22:14 UTC | Cibus, Inc. CBUS · Entity 6658 | GrantStock Option (Right-to-Buy) · Derivative | 119,500 | $0.00 Strike: $2.20 | $0.00 |
DisclosureSEC source: 0001615594-25-000047 · primary_doc.xml · derivative · entry 2 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 119,500 Underlying: Class A Common Stock · 119,500 shares Expires 2035-03-24 F1 · derivative.exercise_date: Options vest substantially equally each month until March 24, 2029 Read SEC document |
| March 24, 2025 Filed Mar 27, 2025 22:14 UTC | Cibus, Inc. CBUS · Entity 6658 | GrantClass A Common Stock | 60,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001615594-25-000047 · primary_doc.xml · nonDerivative · entry 1 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 374,844 Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 20:10 UTC | Cibus, Inc. CBUS · Entity 6658 | SaleClass A Common Stock | 2,000 | $10.01 | $20,022.60 |
DisclosureSEC source: 0001615594-24-000038 · primary_doc.xml · nonDerivative · entry 1 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 314,844 F1 · price: The price reported is a weighted average. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.03, inclusive. F2 · balance_after: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by reporting person on March 27, 2024. Read SEC document |
| July 12, 2024 Filed Jul 15, 2024 21:07 UTC | Cibus, Inc. CBUS · Entity 6658 | SaleClass A Common Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001615594-24-000037 · primary_doc.xml · nonDerivative · entry 1 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,844 F1 · balance_after: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2024. Read SEC document |
| June 27, 2024 Filed Jul 15, 2024 21:03 UTC | Cibus, Inc. CBUS · Entity 6658 | SaleClass A Common Stock | 2,000 | $10.00 | $20,000.00 |
DisclosureSEC source: 0001615594-24-000036 · primary_doc.xml · nonDerivative · entry 1 Gocal Gregory Francis William · CIK 0001976142 · Chief Scientific Officer & EVP 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 318,844 F1 · balance_after: The reported sale occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2024. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 11:05 UTC | Cibus, Inc. CBUS · Entity 6658 | GrantClass A Common Stock | 78,522 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-014323 · doc4.xml · nonDerivative · entry 2 Gocal Gregory Francis William · CIK 0001976142 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 320,844 F2 · price: Gives effect to the 1-for-5 reverse stock split of Calyxt's common stock on May 31, 2023. On the closing date, the closing price of Calyxt's common stock was $6.30. Upon closing, Calyxt was renamed "Cibus, Inc.", the Issuer's Amended and Restated Certificate was amended such that the Issuer had two classes of common stock (Class A Common Stock and Class B Common Stock), and Calyxt's existing common stock remained as Class A Common Stock. F3 · price: Represents substitute awards constituting restricted shares of Class A Common Stock granted and issued pursuant to the Cibus, Inc. 2017 Omnibus Incentive Plan upon the closing of the transactions contemplated by the Merger Agreement (the "Transactions"), whereby certain Cibus restricted profits interest units previously granted to employees of Cibus were automatically cancelled and converted into the right to receive a number of restricted shares of the Class A Common Stock, subject to the same vesting schedule as was applicable to such profits interests units prior to the closing of the Transactions. Read SEC document |
| May 31, 2023 Filed Jun 2, 2023 11:05 UTC | Cibus, Inc. CBUS · Entity 6658 | GrantClass A Common Stock | 242,322 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-014323 · doc4.xml · nonDerivative · entry 1 Gocal Gregory Francis William · CIK 0001976142 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,322 F1 · price: Represents shares of Class A Common Stock received as consideration in connection with the closing of the transactions contemplated by the Agreement and Plan of Merger, dated January 13, 2023, as amended by the First Amendment to the Merger Agreement, dated April 14, 2023 (as amended, the "Merger Agreement"), by and among Cibus, Inc. (formerly Calyxt, Inc.) (the "Issuer", and prior to the closing of the transactions contemplated by the Merger Agreement, "Calyxt"), Calypso Merger Subsidiary, LLC, Cibus Global, LLC ("Cibus") and certain blocker entities party thereto. F2 · price: Gives effect to the 1-for-5 reverse stock split of Calyxt's common stock on May 31, 2023. On the closing date, the closing price of Calyxt's common stock was $6.30. Upon closing, Calyxt was renamed "Cibus, Inc.", the Issuer's Amended and Restated Certificate was amended such that the Issuer had two classes of common stock (Class A Common Stock and Class B Common Stock), and Calyxt's existing common stock remained as Class A Common Stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.